Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies
Authors
Keywords
-
Journal
HLA
Volume 88, Issue 5, Pages 213-220
Publisher
Wiley
Online
2016-09-23
DOI
10.1111/tan.12898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy
- (2016) Christoph Domschke et al. Breast Care
- Role of the tumor microenvironment in regulating apoptosis and cancer progression
- (2016) Katherine Yaacoub et al. CANCER LETTERS
- Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
- (2016) F. Zhao et al. CANCER RESEARCH
- PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
- (2016) Sara Gandini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Monitoring immune responses in the tumor microenvironment
- (2016) Jennifer A Wargo et al. CURRENT OPINION IN IMMUNOLOGY
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
- (2016) Lucia Festino et al. DRUGS
- Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
- (2016) Sarah J. Welsh et al. EUROPEAN JOURNAL OF CANCER
- Mouse models for studies of HLA-G functions in basic science and pre-clinical research
- (2016) Anh Thu Nguyen-Lefebvre et al. HUMAN IMMUNOLOGY
- Role of microRNAs on HLA-G expression in human tumors
- (2016) Barbara Seliger HUMAN IMMUNOLOGY
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Reverse immunoediting: When immunity is edited by antigen
- (2016) Anna Merlo et al. IMMUNOLOGY LETTERS
- Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
- (2016) Murali Janakiram et al. Immunotherapy
- Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors
- (2016) Ryan Gentzler et al. Immunotherapy
- Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
- (2016) Stefani Spranger INTERNATIONAL IMMUNOLOGY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma
- (2016) Maria I. Carlo et al. Nature Reviews Urology
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells
- (2016) Fernando Concha-Benavente et al. ORAL ONCOLOGY
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
- (2016) Lidia Robert et al. SEMINARS IN IMMUNOLOGY
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- Mechanisms of tumor cell resistance to the current targeted-therapy agents
- (2016) Gholamreza Khamisipour et al. TUMOR BIOLOGY
- Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
- (2016) Ellen Stelloo et al. Oncotarget
- The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
- (2016) Vera Rebmann et al. Frontiers in Immunology
- Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma
- (2016) Melina E. Marmarelis et al. Journal for ImmunoTherapy of Cancer
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
- (2015) K Abiko et al. BRITISH JOURNAL OF CANCER
- Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance
- (2015) Francisco Javier Carretero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- (2015) Katia R M Leite et al. Diagnostic Pathology
- HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
- (2015) Rosa Sottile et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genetics, genomics, and evolutionary biology of NKG2D ligands
- (2015) Raphael Carapito et al. IMMUNOLOGICAL REVIEWS
- Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
- (2015) Chien-Chung Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Overcoming Resistance to Targeted Therapies in Cancer
- (2015) Keara L. Redmond et al. SEMINARS IN ONCOLOGY
- Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future Directions
- (2015) Michael Atkins SEMINARS IN ONCOLOGY
- Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
- (2015) Roberto Iacovelli et al. Targeted Oncology
- High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma
- (2015) S. Samuels et al. TISSUE ANTIGENS
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- Suppression of T cell responses in the tumor microenvironment
- (2015) Alan B. Frey VACCINE
- NLRC5 Exclusively Transactivates MHC Class I and Related Genes through a Distinctive SXY Module
- (2015) Kristina Ludigs et al. PLoS Genetics
- BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma
- (2015) S. D. Bradley et al. Cancer Immunology Research
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
- (2015) Jinyu Zhang et al. Frontiers in Immunology
- Novel Immune Check-Point Regulators in Tolerance Maintenance
- (2015) Yanxia Guo et al. Frontiers in Immunology
- Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma
- (2015) Simon Jasinski-Bergner et al. OncoImmunology
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape
- (2015) Mariarosaria Conte et al. Oncotarget
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- Tumor Hypomethylation at 6p21.3 Associates with Longer Time to Recurrence of High-Grade Serous Epithelial Ovarian Cancer
- (2014) C. Wang et al. CANCER RESEARCH
- Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
- (2014) A. Sucker et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Orchestrating immune check-point blockade for cancer immunotherapy in combinations
- (2014) Jose Luis Perez-Gracia et al. CURRENT OPINION IN IMMUNOLOGY
- Expression of stress ligands of the immunoreceptor NKG2D in melanoma: Regulation and clinical significance
- (2014) Annette Paschen et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Overcoming tumor-mediated immunosuppression
- (2014) Hans Anton Schlößer et al. Immunotherapy
- Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
- (2014) L Crucitti et al. LEUKEMIA
- The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
- (2014) Sandra S. McAllister et al. NATURE CELL BIOLOGY
- Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade
- (2014) Janis M Taube OncoImmunology
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
- (2012) Monica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner
- (2012) A. Neerincx et al. JOURNAL OF IMMUNOLOGY
- NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression
- (2012) T. B. Meissner et al. JOURNAL OF IMMUNOLOGY
- The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells
- (2012) Irene Romero et al. JOURNAL OF PATHOLOGY
- Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women
- (2012) Ayshamgul Hasim et al. PLoS One
- The role of classical and non-classical HLA class I antigens in human tumors
- (2012) Juergen Bukur et al. SEMINARS IN CANCER BIOLOGY
- Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia
- (2012) Luca Vago et al. SEMINARS IN ONCOLOGY
- Targeting HLA class I expression to increase tumor immunogenicity
- (2012) A. B. del Campo et al. TISSUE ANTIGENS
- Hallmarks of cancer: of all cancer cells, all the time?
- (2012) Sébastien L. Floor et al. TRENDS IN MOLECULAR MEDICINE
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Novel insights into the molecular mechanisms of HLA class I abnormalities
- (2011) Barbara Seliger CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Association of IFN- Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
- (2011) A. Respa et al. CLINICAL CANCER RESEARCH
- HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
- (2011) Michael Campoli et al. Seminars in Immunopathology
- The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions
- (2010) Federico Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of an alternate splice form of tapasin in human melanoma
- (2010) Alan Belicha-Villanueva et al. HUMAN IMMUNOLOGY
- Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression
- (2010) Juergen Bukur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
- (2010) T. B. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive immunotherapy of cancer using CD4+ T cells
- (2009) Pawel Muranski et al. CURRENT OPINION IN IMMUNOLOGY
- What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?
- (2009) Alan Belicha-Villanueva et al. IMMUNOLOGIC RESEARCH
- Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
- (2009) Christine Sers et al. INTERNATIONAL JOURNAL OF CANCER
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer
- (2009) Q. Ye et al. TISSUE ANTIGENS
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
- (2008) M Campoli et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now